Inventor · disambiguated record
Lawrence Steinman
Also filed as: STEINMAN LAWRENCE · STEINMAN LAWRENCE M
36 granted patents·33 pending applications·402 citations·filing 1984–2022
97Inventor score
Files withUNIV LELAND STANFORD JUNIOR32STEINMAN LAWRENCE7NEUROCRINE BIOSCIENCES INC4STANFORD UNIVERSITY MEDICAL CT2AXTELL ROBERT C1
Top patents by PatentIndex Score
69 records- 0187US4695459AMethod of treating autoimmune diseases that are mediated by Leu3/CD4 phenotype T cellsUNIV LELAND STANFORD JUNIOR·Filed 1984·Granted Sep 22, 1987·65 cites·7 claims
- 0286US7030098B2DNA vaccination for treatment of autoimmune diseaseUNIV LELAND STANFORD JUNIOR·Filed 2001·Granted Apr 18, 2006·21 cites·7 claims
- 0381US5939400ADNA vaccination for induction of suppressive T cell responseUNIV LELAND STANFORD JUNIOR·Filed 1996·Granted Aug 17, 1999·66 cites·6 claims
- 0480US10034915B2Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemiaSTEINMAN LAWRENCE·Filed 2012·Granted Jul 31, 2018·2 cites·2 claims
- 0580US6531130B1Treatment of demyelinating autoimmune disease with ordered peptidesUNIV LELAND STANFORD JUNIOR·Filed 2000·Granted Mar 11, 2003·8 cites·4 claims
- 0680US6489299B2Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic proteinSTANFORD UNIVERSITY MEDICAL CT·Filed 2001·Granted Dec 3, 2002·12 cites·4 claims
- 0778US7704970B2DNA vaccination for treatment of autoimmune diseaseUNIV LELAND STANFORD JUNIOR·Filed 2007·Granted Apr 27, 2010·2 cites·2 claims
- 0878US7544669B2Polynucleotide therapyUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Jun 9, 2009·11 cites·39 claims
- 0978US6794414B1Method and compositions for treating diseases mediated by transglutaminase activityYEDA RES & DEV·Filed 1999·Granted Sep 21, 2004·54 cites·15 claims
- 1078US5667967AT-cell receptor varible transcripts as disease related markersUNIV LELAND STANFORD JUNIOR·Filed 1993·Granted Sep 16, 1997·85 cites·6 claims
- 1177US7579328B2DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitusUNIV LELAND STANFORD JUNIOR·Filed 2005·Granted Aug 25, 2009·2 cites·10 claims
- 1275US7875589B2Alpha B-crystallin as a therapy for rheumatoid arthritisUNIV LELAND STANFORD JUNIOR·Filed 2007·Granted Jan 25, 2011·2 cites·10 claims
- 1375US7070780B2Treatment of demyelinating autoimmune disease with ordered peptidesUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Jul 4, 2006·4 cites·6 claims
- 1474US8748404B2DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitusSTEINMAN LAWRENCE·Filed 2010·Granted Jun 10, 2014·2 cites·7 claims
- 1573US10543260B2Replacement gene tolerizing vectors and methods of use thereofUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Jan 28, 2020·1 cites·4 claims
- 1673US8828668B2Markers for determination of patient responsivenessAXTELL ROBERT C·Filed 2011·Granted Sep 9, 2014·7 cites·19 claims
- 1771US8148084B2Diagnosis of autoimmune diseaseO'CONNOR KEVIN C·Filed 2007·Granted Apr 3, 2012·3 cites·15 claims
- 1871US6740638B2Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 2002·Granted May 25, 2004·3 cites·4 claims
- 1969US8071744B2TRP/HIS exchange and kynurenin induced TRP transportKAPER THIJS·Filed 2011·Granted Dec 6, 2011·2 cites·14 claims
- 2069US2023014308A1Treatment of neuroinflammatory diseaseUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 2167US7785819B2Therapeutic and diagnostic uses of antibody specificity profilesUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Aug 31, 2010·3 cites·18 claims
- 2265US9140701B2Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthritisROBINSON WILLIAM H·Filed 2010·Granted Sep 22, 2015·1 cites·4 claims
- 2364US2020000871A1B-1a lymphocyte and/or macrophage targeting and activation to treat medical conditions with inflammatory or autoimmune componentsUNIV LELAND STANFORD JUNIOR·Filed 2019·Application pending·0 cites
- 2463US7811813B2Methods and immune modulatory nucleic acid compositions for preventing and treating diseaseUNIV LELAND STANFORD JUNIOR·Filed 2003·Granted Oct 12, 2010·2 cites·11 claims
- 2561US2009264515A1Polynucleotide therapyUNIV LELAND STANFORD JUNIOR·Filed 2009·Application pending·0 cites
- 2661US2009281170A1Polynucleotide therapyUNIV LELAND STANFORD JUNIOR·Filed 2009·Application pending·0 cites
- 2760US8257700B2Proteomic analysis of active multiple sclerosis lesionsSTEINMAN LAWRENCE M·Filed 2009·Granted Sep 4, 2012·1 cites·4 claims
- 2860US2018346577A1Treatment of neuroinflammatory diseaseUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
- 2959US2016068585A1Compositions and methods for treatment of type 1 diabetesTOLERION·Filed 2014·Application pending·0 cites
- 3059US2019184007A1Avoiding narcolepsy risk in influenza vaccinesSeqirus UK Limted·Filed 2019·Application pending·0 cites
- 3158US8252775B2Method of treating multiple sclerosis with phosphocholine containing lipidsKANTER JENNIFER L·Filed 2006·Granted Aug 28, 2012·2 cites·5 claims
- 3258US6329499B1Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 1994·Granted Dec 11, 2001·10 cites·8 claims
- 3357US10098935B2Aquaporin tolerizing vaccines and methods of use thereofUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Oct 16, 2018·0 cites·7 claims
- 3457US2019315827A1Compositions and methods for treatment of type 1 diabetesTOLERION INC·Filed 2018·Application pending·0 cites
- 3557US2019083594A1Aquaporin tolerizing vaccines and methods of use thereofUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
- 3657US2010129376A1Osteopontin Specific Antibodies and Methods of Use ThereofDENHARDT DAVID T·Filed 2009·Application pending·0 cites
- 3757US2004214775A1Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 3856US7935494B2Trp/his exchange and kynurenine induced Trp transportCARNEGIE INST OF WASHINGTON·Filed 2008·Granted May 3, 2011·0 cites·5 claims
- 3954US9610326B2Amyloid beta peptides as therapy for multiple sclerosisUNIV LELAND STANFORD JUNIOR·Filed 2012·Granted Apr 4, 2017·0 cites·3 claims
- 4054US7282490B2Osteopontin-related compositions and methodsUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Oct 16, 2007·1 cites·10 claims
- 4154US5000952APolypeptide pertussis toxin vaccineUNIV LELAND STANFORD JUNIOR·Filed 1988·Granted Mar 19, 1991·7 cites·10 claims
- 4253US2014335116A1Avoiding narcolepsy risk in influenza vaccinesNOVARTIS AG·Filed 2014·Application pending·0 cites
- 4352US5532265ATreatment of central nervous system inflammatory disease with matrix metalloprotease inhibitorsUNIV LELAND STANFORD JUNIOR·Filed 1994·Granted Jul 2, 1996·20 cites·10 claims
- 4452US2016146831A1Antibody and Cytokine Biomarker Profiling for Determination of Patient ResponsivenessUNIV LELAND STANFORD JUNIOR·Filed 2015·Application pending·0 cites
- 4552US2013108624A1Cryptic glycan markers and applications thereofUNIV LELAND STANFORD JUNIOR·Filed 2012·Application pending·0 cites
- 4651US2008026485A1Antibody profiling for determination of patient responsivenessHUEBER WOLFGANG·Filed 2007·Application pending·0 cites
- 4750US7867976B2Nogo epitopic fragments for modulating immune responseUNIV LELAND STANFORD JUNIOR·Filed 2004·Granted Jan 11, 2011·0 cites·1 claims
- 4850US2014161786A1Therapeutic compositions and related methodsROTHBARD JONATHAN B·Filed 2013·Application pending·0 cites
- 4950US2015079083A1Alpha B-Crystallin as a Therapy for Ischemia or InflammationUNIV LELAND STANFORD JUNIOR·Filed 2014·Application pending·0 cites
- 5049US8771689B2Alpha B-crystallin as a therapy for ischemia or inflammationSTEINMAN LAWRENCE·Filed 2011·Granted Jul 8, 2014·0 cites·7 claims
Showing the top 50 of 69 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →